Skip to navigation Skip to main content

Lenvatinib (Lenvima)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews lenvatinib (Lenvima), indicated for the treatment ofLocally recurrent or metastatic, progressive radioactive iodine-refractory differentiated thyroid cancer or advanced renal cell carcinoma following 1 prior anti-angiogenic therapy.

Table of Contents

Slide 4: Dosage and Administration
Slide 15: Cautions, Effects, and Interactions
Slide 25: What to Tell Your Patient
Slide 33: Reference

Topics:

Drug Information Slideshows Stat Consult
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next hm-slideshow in Slides